Pilot Study to Assess the Difference in Glycemic Profiles Between Vildagliptin and Glimepiride Using Continuous Glucose Monitoring Device.
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2013
At a glance
- Drugs Vildagliptin (Primary) ; Glimepiride; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 01 Oct 2012 Primary endpoint 'Mean-Amplitude-of-Glycaemic-Excursion' has not been met.
- 01 Oct 2012 Primary endpoint 'Glucose-level' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History